New CMS Alzheimer's drug coverage plan raises questions around worth
A Medicare plan for covering new Alzheimer's drugs treatments is reviving thorny questions about whether pricey treatments with modest success slowing the disease's progression are worth the cost and safety concerns.Driving the news: The Centers for Medicare and Medicaid Services on Thursday outlined conditions under which it would expand coverage for a specific class of…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Flood insurance rates spur lawsuit
Health insurance renewal scam targeting some New Yorkers
Advisor News
- Trump bets his tax cuts will please Las Vegas voters on his swing West
- Lifetime income is the missing link to global retirement security
- Don’t let caregiving derail your clients’ retirement
- The ‘magic number’ for retirement hits $1.45M
- OBBBA can give small-business clients opportunities for saving
More Advisor NewsAnnuity News
- Human connection still key in the new annuity era
- Lifetime income is the missing link to global retirement security
- ‘All-weather’ annuity portfolios aim to sharply limit rainy days
- Annuity income: The new 401(k) standard?
- Smart annuity planning can benefit long-term tax planning
More Annuity NewsHealth/Employee Benefits News
- Trump admin seeks health-care price transparency
- OID approved in effort to make health coverage more affordable
- MEDICAID COST-SHARING COVERAGE VETO SUSTAINED
- MEDICAID COST-SHARING COVERAGE APPROVED
- DeSantis administration gets pushback for its child health policies
More Health/Employee Benefits NewsLife Insurance News
- AI and life insurance: Fast today, unpredictable tomorrow
- Judge allows PHL policyholders to intervene, denies ‘premium holiday’
- eHealth expands into final expense insurance
- CID hosts info session for PHL Variable policyholders
- ‘Seismic changes’ cloud global economy, analyst says
More Life Insurance News